Oman vs Zambia: Share of E. coli infections resistant to cephalosporins
Oman
78.2%
in 2022
Zambia
76.5%
in 2022
Oman rank
3rd
Zambia rank
6th
Share of E. coli infections resistant to cephalosporins over time
- Oman
- Zambia
How they compare
Oman currently reports 78.2% against 76.5% in Zambia, a difference of 1.7%.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Zambia ahead.
Oman ranks 3rd and Zambia ranks 6th of 46 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oman | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.1% | 57.5% | 5.4% | Zambia |
| 2020s | 73.7% | 88.4% | 14.7% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Oman or Zambia?
- Oman, at 78.2% against 76.5% in Zambia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Oman and Zambia?
- 1.7%, with Oman ahead.
- How many years of comparable data are there for Oman and Zambia?
- 5 years are reported by both, from 2017 to 2022.
- How do Oman and Zambia rank globally for share of e. coli infections resistant to cephalosporins?
- Oman ranks 3rd and Zambia ranks 6th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).